Skip to main content

Language: English / Gàidhlig

Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 5 May 2021
  6. Current session: 12 May 2021 to 29 January 2023
Answer status
Question type
Reset filter

Displaying 1031 questions Show Answers

|

Question reference: S3W-40155

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Shona Robison on 16 March 2011

To ask the Scottish Executive when the sub-group of the Breast and Cervical Screening National Advisory Group will report its findings on the review of the integration of human papilloma virus (HPV) testing in the cervical screening programme and when the findings will be published.

Question reference: S3W-40158

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Shona Robison on 16 March 2011

To ask the Scottish Executive what costs are associated with the cervical screening programme.

Question reference: S3W-40157

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Shona Robison on 16 March 2011

To ask the Scottish Executive what the (a) sensitivity and (b) specificity is of the cervical screening programme.

Question reference: S3W-40156

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Shona Robison on 16 March 2011

To ask the Scottish Executive what plans it has to introduce triage for human papilloma virus (HPV) into the cervical screening programme in order to reduce the number of women requiring repeat screening after detection of borderline abnormalities.

Question reference: S3W-40154

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Shona Robison on 16 March 2011

To ask the Scottish Executive who the members are of the sub-group of the Breast and Cervical Screening National Advisory Group who will review the integration of human papilloma virus (HPV) testing in the cervical screening programme.

Question reference: S3W-40160

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Nicola Sturgeon on 14 March 2011

To ask the Scottish Executive what costs were associated with biopsy for and treatment of cervical cancer in the last year for which information is available.

Question reference: S3W-40159

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Nicola Sturgeon on 14 March 2011

To ask the Scottish Executive what costs are associated with performing a colposcopy and how many were performed in the last year for which information is available.

Question reference: S3W-40152

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Thursday, 03 March 2011
  • Current Status: Answered by Nicola Sturgeon on 4 March 2011

To ask the Scottish Executive whether it will announce additional support for people infected with hepatitis C or HIV through NHS treatment with blood or blood products.

Question reference: S3W-39739

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Monday, 21 February 2011
  • Current Status: Answered by Nicola Sturgeon on 22 February 2011

To ask the Scottish Executive whether it will consider changing the terms of reference of the Penrose inquiry investigating the circumstances in which patients were infected with hepatitis C or HIV following treatment, in light of evidence found by the inquiry.

Question reference: S3W-39064

  • Asked by: Michael Matheson, MSP for Falkirk West, Scottish National Party
  • Date lodged: Wednesday, 26 January 2011
  • Current Status: Answered by Jim Mather on 7 February 2011

To ask the Scottish Executive what action is being taken to overcome the delay in wind farm projects due to radar issues and when the matter will be resolved with aviation stakeholders